Matoke® Pharma’s Managing Director, Alan Westwood, writes for Pharmafield on investment in antibiotic research

Pharmafield, “The UK as a global leader in antimicrobial resistance” , 15th April 2019

Alan Westwood, Matoke® Pharma’s Managing Director, writes in Pharmafield discussing the medical need, the UK policy environment and the requirements both from the UK Government and the pharmaceutical industry to overcome the global challenge of antimicrobial resistance.

“The pharmaceutical and biotechnology industry must be bold and aggressive in its investment in the space and pursue partnerships to extend research in drug discovery, delivery mechanisms and clinical research innovation.”

Matoke® Pharma is working to develop novel antimicrobial products that can help overcome the threat of resistance based on Reactive Oxygen® technology, which has the potential for biofilm penetration, tissue regeneration, wound healing and immune system stimulation.

To read the article, click here.

Leave a Reply

Your email address will not be published. Required fields are marked *